News

Owner Vita Nova Ventures acquires SEDOC PM

August 31, 2007
Vita Nova Ventures AB takes over SEDOC Pharmaceutical Medicine AB. SEDOC is a Contract Research Organisation, CRO. The company plans and carries out clinical trials for Swedish and international pharmaceutical, biotechnical and medico-technical companies. The purchase price consists of a cash payment and 110 million Vita Nova Ventures shares. SEDOC will be incorporated into Vita Nova Ventures’ subsidiary A+ Science AB.

Vita Nova Ventures enters into an agreement of acquisition with SEDOC PM

August 08, 2007
Vita Nova Ventures AB has signed a Letter of Intent for the acquisition of all of the shares in SEDOC Pharmaceutical Medicine AB. SEDOC AB is at present owned by Arandi Development AB. Final negotiations and finalisation of the contract are in progress. If the deal is completed Vita Nova Ventures will take possession on the 31st August 2007. The purchase price will be paid partly in cash and partly in Vita Nova Ventures shares.

Upcoming events


Copyright © 1997-2009 A+ Science AB. or its subsidiaries. All rights reserved.